Search Results
Viewing: 801-810 of 3169 | All
News
New Center at Nationwide Children's Hospital Receives Significant NIH Funding
Researchers at Nationwide Children's Hospital recently received coveted P50 Center grant funding from the National Institute of Mental Health (NIMH), part of the National Institutes of Health (NIH), to support a new center focused on suicide prevention.
News
Bicycle-related Injuries Send 25 Children to Emergency Departments Every Hour
A new study conducted by researchers in the Center for Injury Research and Policy of the Research Institute at Nationwide Children’s Hospital, published online in Accident Analysis & Prevention, found that from January 2006 through December 2015, more than 2.2 million children age 5-17 years were treated in US hospital emergency departments for bicycle-related injuries. This averages 608 cases per day or 25 every hour.
Article
Fellowship Curriculum
The Hemostasis-Thrombosis Fellowship curriculum is somewhat flexible in order to accommodate the unique learning needs of the matriculated fellowship applicant, which may be dependent on their ultimate career goals and/or designed to build upon their past experiences. Learn about these opportunities and the minimum expectations.
Article
Scholarly Activity/ Research Activity Assignment Goals and Objectives
Scholarly activity is necessary for the pediatric otolaryngology fellow’s personal and professional development and program improvement. To foster the fellow’s growth and development of new knowledge, understanding, and appreciation of evidence based medicine through scholarly activity,
News
Researchers Find Relationship, Behavioral Differences between Children and Early Adolescents Who Die by Suicide
According to the Centers for Disease Control and Prevention (CDC), suicide was the 10th leading cause of death for children ages 5 to 11 in 2014. This was the first time suicide had shown up in the CDC’s top ten leading causes of death for children in this age group.
Article
Rajappa Lab
Under the direction of Prajwal Rajappa, MD, MS, the Rajappa Laboratory at the Steve and Cindy Rasmussen Institute for Genomic Medicine focuses on precision medicine and immunotherapy for patients diagnosed with central nervous system (CNS) tumors.
News
Nationwide Foundation Pediatric Innovation Fund Accelerating Lifesaving Progress at Newly-Formed Institute For Genomic Medicine at Nationwide Childrens Hospital
The Nationwide Foundation today announced a new $10 million gift for the Nationwide Foundation Pediatric Innovation Fund at Nationwide Children’s Hospital to help accelerate the most promising research and clinical discoveries at Nationwide Children’s.
Article
Saad Lab
Under the direction of Nizar Saad, MSc, PhD, the Saad Lab conducts cutting-edge research to understand the causes of genetic disorders, including neuromuscular diseases, and develops innovative techniques to diagnose, treat and cure these conditions.
News
St. Baldrick's Foundation Funds $8.9 Million in Grants to Support the Most Promising Childhood Cancer Research
No hospital has a monopoly on good ideas. This is why the St. Baldrick's Foundation funds the most promising research — no matter where it takes place – from your backyard institution to other cutting edge research facilities treating childhood cancers around the globe. Since 2005, this philosophy has translated to more than 1,674 grants in 31 countries, totaling more than $322 million. Thanks to the tremendous efforts of volunteers, donors, partners and advocates across the country this past year, St. Baldrick's is proud to announce $8.9 million has been awarded in new grants.
News
Human MicroRNA Inhibits Expression of Pathogenic Gene Underlying Facioscapulohumeral Muscular Dystrophy
Facioscapulohumeral muscular dystrophy (FSHD) is caused by aberrant expression of the DUX4 gene in skeletal muscles. Researchers at Nationwide Children’s Hospital have recently demonstrated that an endogenous human microRNA, miR-675, inhibits DUX4 expression and protects muscles from DUX4-mediated cell death in a mouse model when administered via gene therapy. They also showed that the small molecule-based treatments that upregulate miR-675 inhibited DUX4 mRNA and DUX4-associated biomarkers in myotubes derived from patients with FSHD.